Sales & Marketing Sponsored Stress-testing day one: Designing and preparing for a flawle... The pressure to execute a flawless drug or therapy launch has never been greater and continues to lay the foundation for long-term product success.
Market Access Aduhelm and an expensive failure to launch Biogen’s treatment for Alzheimer’s was initially regarded as a major treatment breakthrough.
Sales & Marketing Is the UK an attractive launch market? Leela Barham tries to cut through the lobbying to identify objective measures of the attractiveness of the UK market for launching new medicines.
Views & Analysis What makes a good (and bad) pharmaceutical forecast model Forecasting is essential in providing clarity on decision making about the future, but poor-quality forecasts can result in decisions which are commercially damaging to organisations.
Oncology Hernexeos and what’s next, with Vicky Brown At Reuters Pharma USA this week, Boehringer Ingelheim's Vicky Brown spoke with us about the company's recent approval for Hernexeos in NSCLC.
Sales & Marketing Sponsored Using AI-driven synthetic personas to take your insights fur... As AI continues to reshape the healthcare landscape, pharma teams are beginning to leverage synthetic personas.